Tolvaptan: a new tool for the effective treatment of hyponatremia in psychotic disorders.
作者： Richard C Josiassen , Jessica Curtis , Dawn M Filmyer , Brett Audino , Nina Skuban
DOI: 10.1517/14656561003610656
关键词:
摘要: Importance of the field: Hyponatremia (serum sodium concentration < 136 mEq/liter) is a common and potentially life-threatening medical comorbidity seen in patients with psychotic disorders. Tolvaptan, selective antagonist V2-receptor, FDA-approved for treatment clinically significant hypervolemic euvolemic hyponatremia. This represents major development care individuals hyponatremia.Areas covered review: review provides an overview existing literature on prevalence rates risk factors associated hyponatremia (1923 – present). Tolvaptan discussed as potential advance disorders, preliminary data are reviewed.What reader will gain: The gain appreciation among individuals, understanding distinctions between acute chronic this population, awareness ...
informahealthcare.com参考文章(72)
Masao Okura, Shoji Morii, Polydipsia, polyuria and water intoxication observed in psychiatric inpatients. The Tokushima journal of experimental medicine. ,vol. 33, pp. 1- 5 ,(1986)
Gary L. Robertson, ANTIDIURETIC HORMONE : Normal and Disordered Function Endocrinology and Metabolism Clinics of North America. ,vol. 30, pp. 671- 694 ,(2001) , 10.1016/S0889-8529(05)70207-3
Incidence and morbidity of self-induced water intoxication in state mental hospital patients American Journal of Psychiatry. ,vol. 136, pp. 221- 222 ,(1979) , 10.1176/AJP.136.2.221
SCHIZOPHRENIA FROM THE PHYSIOLOGICAL POINT OF VIEW Annals of Internal Medicine. ,vol. 7, pp. 445- 456 ,(1933) , 10.7326/0003-4819-7-4-445
Tolvaptan for hyponatremia. The New England Journal of Medicine. ,vol. 356, pp. 961- ,(2007) , 10.1056/NEJMC063545
Guy Brookes, AG Ahmed, Pharmacological treatments for psychosis‐related polydipsia Cochrane Database of Systematic Reviews. ,(2006) , 10.1002/14651858.CD003544.PUB2
Kenji Tsujimae, Michiaki Tominaga, Toshiyuki Onogawa, Kazumi Kondo, Takahiro Hirano, Yoshihisa Yamada, Shuji Itoh, Hidenori Ogawa, Shigeki Nakamura, Toyoki Mori, Tatsuya Yamashita, Hiroshi Yamashita, Masashi Aoyama, Yoshitaka Yamamura, Kounori Kotosai, Gozoh Tsujimoto, OPC-41061, a Highly Potent Human Vasopressin V2-Receptor Antagonist: Pharmacological Profile and Aquaretic Effect by Single and Multiple Oral Dosing in Rats Journal of Pharmacology and Experimental Therapeutics. ,vol. 287, pp. 860- 867 ,(1998)
J. J. F. Taljaard, H. Van Der Meer, C. Aalbers, R. A. Emsley, Inappropriate antidiuretic state in long-term psychiatric inpatients. South African Medical Journal. ,vol. 77, pp. 307- 308 ,(1990)
W. V. R. VIEWEG, J. J. DAVID, W. T. ROWE, G. J. WAMPLER, W. J. BURNS, W. W. SPRADLIN, Death from self-induced water intoxication among patients with schizophrenic disorders. Journal of Nervous and Mental Disease. ,vol. 173, pp. 161- 165 ,(1985) , 10.1097/00005053-198503000-00005
Lisa L Wong, Joseph G Verbalis, Vasopressin V2 receptor antagonists. Cardiovascular Research. ,vol. 51, pp. 391- 402 ,(2001) , 10.1016/S0008-6363(01)00315-7